Rare diseases
Investigational molecules
Locations
611 Gateway Boulevard Ste 900, 94080-7029, United States
Clinical research is centered on advanced and metastatic solid tumors, with attention to tumors driven by RET alterations and treatment settings where targeted therapy is relevant.
The sponsor’s trial activity in this area reflects interest in precision oncology and the clinical management of patients with advanced malignant disease.
Rigel Pharmaceuticals Inc. runs clinical trials in conditions such as Neoplasm, among others.
Clinical trials run by this sponsor – those enrolling participants first.
SpainIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
